Log In
Print
BCIQ
Print
Print this Print this
 

ISIS-GCGRRx

Also known as: formerly ISIS-GCGR

  Manage Alerts
Collapse Summary General Information
Company Isis Pharmaceuticals Inc.
DescriptionAntisense inhibitor targeting glucagon receptor (GCGR)
Molecular Target Glucagon receptor (GCGR)
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today